Prestige Biopharma Enters MOU with Vaxine for Supply of COVID-19 Vaccine and Co-development of COVID-19/Influenza Combo Vaccine

SINGAPORE, March 30 (Bernama-BUSINESS WIRE) — Prestige Biopharma Limited and Vaxine Pty Ltd announced that the two organizations have entered into a memorandum of understanding (MOU) to collaborate on the supply of Vaxine’s COVID-19 Vaccine, Covax-19^® (also known as Spikogen^®) and on the co-development of COVID-19/influenza combo vaccine.

http://mrem.bernama.com/viewsm.php?idm=42780